ALLOGENEIC PERIPHERAL BLOOD AND BONE MARROW STEM CELL TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA: A SINGLE CENTER STUDY

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

GHAVAMZADEH ARDESHIR; IRAVANI M.; JAHANI M.; BAHAR B.; MOUSAVI A.; GHOLIBEIKIAN S.; JAFARI M.; SAFAVIFAR F.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ACTA MEDICA IRANICA Year:2003 | Volume:41 | Issue:4 Page(s): 220-226

Download Full-Text

View:

252

Download:

Cites:

Information Journal Paper

Title

ALLOGENEIC PERIPHERAL BLOOD AND BONE MARROW STEM CELL TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA: A SINGLE CENTER STUDY

Author(s)

Keywords

CHRONIC MYELOID LEUKEMIA

ALLOGENEIC BMT

PERIPHERAL BLOOD STEM CELL TRANSPLANTATION

BONE MARROW STEM CELL TRANSPLANTATION

Abstract

In this center, from 1991 to 2002, 89 chronic myelogenous leukemic (CML) patients, age ranging between 8-48 years with a median age of 29, underwent hematopoietic stem cell transplantation. Eighty-eight patients were in the first chronic phase of disease. Twenty-three patients received bone marrow transplantation (BMT) and 66 patients received peripheral blood stem cell transplantations (PBSCT). Transplantation was performed at a median interval of 19 months post-diagnosis. All with five exceptions received busulfan + cyclophosphamide (Bu Cy) conditioning regimens. To maintain graft vs. host disease (GVHD) prophylaxis, all with three exceptions received cyclosporine + metothrexate. Administration of granulocyte colony stimulating factor (G-CSF), per protocol, was included in post-transplantation regimens from the year 1999 on 48 patients. All patients received marrow transplantations from sibling donors. Fifty seven of transplanted patients are alive. Disease free survivals (DFS) from 6.2 to 9.5 and from 2.2 to 6.2 years for BMT group were 38.2% and 47.8%, respectively. DFS for PBSCT group was calculated as 54.3% in a period of 1.9 to 4.6 years

Cites

No record.

References

No record.

Cite

APA: Copy

GHAVAMZADEH, ARDESHIR, IRAVANI, M., JAHANI, M., BAHAR, B., MOUSAVI, A., GHOLIBEIKIAN, S., JAFARI, M., & SAFAVIFAR, F.. (2003). ALLOGENEIC PERIPHERAL BLOOD AND BONE MARROW STEM CELL TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA: A SINGLE CENTER STUDY. ACTA MEDICA IRANICA, 41(4), 220-226. SID. https://sid.ir/paper/277627/en

Vancouver: Copy

GHAVAMZADEH ARDESHIR, IRAVANI M., JAHANI M., BAHAR B., MOUSAVI A., GHOLIBEIKIAN S., JAFARI M., SAFAVIFAR F.. ALLOGENEIC PERIPHERAL BLOOD AND BONE MARROW STEM CELL TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA: A SINGLE CENTER STUDY. ACTA MEDICA IRANICA[Internet]. 2003;41(4):220-226. Available from: https://sid.ir/paper/277627/en

IEEE: Copy

ARDESHIR GHAVAMZADEH, M. IRAVANI, M. JAHANI, B. BAHAR, A. MOUSAVI, S. GHOLIBEIKIAN, M. JAFARI, and F. SAFAVIFAR, “ALLOGENEIC PERIPHERAL BLOOD AND BONE MARROW STEM CELL TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA: A SINGLE CENTER STUDY,” ACTA MEDICA IRANICA, vol. 41, no. 4, pp. 220–226, 2003, [Online]. Available: https://sid.ir/paper/277627/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops